Cape Investment Advisory »

Affimed Therapeutics B V shares owned by Cape Investment Advisory

Quarter-by-quarter ownership of Affimed Therapeutics B V shares owned by Cape Investment Advisory from 13F filings

Historical chart of Cape Investment Advisory investment in Affimed Therapeutics B V

Tip: Access up to 7 years of quarterly data

All positions including Affimed Therapeutics B V held by Cape Investment Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Affimed Therapeutics B V by Cape Investment Advisory

Quarter filed Position value Share count Share price at filing
2023-12-31 $63 100 0.63
2023-09-30 $48 100 0.48
2023-06-30 $60 100 0.60
2023-03-31 $75 100 0.75

More positions owned by Cape Investment Advisory

Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Schwab Strategic Tr Us Lcap Va Etf (SCHV)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Apple (AAPL)
Microsoft Corporation (MSFT)
Schwab Strategic Tr Us Mid-cap Etf (SCHM)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Schwab Strategic Tr Emrg Mkteq Etf (SCHE)
Chevron Corporation (CVX)
Janus Detroit Str Tr Hendrsn Shrt Etf (VNLA)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Alphabet Cap Stk Cl C (GOOG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)

View all positions for Cape Investment Advisory

Top funds holding Affimed Therapeutics B V

Ridgeback Capital Investments
683 Capital Management
NEA Management Company
Point72 Asset Management
Millennium Management
Vanguard Group
Two Sigma Advisers
Kennedy Capital Management
Two Sigma Investments
Marshall Wace
Alyeska Investment Group
Standard Life Aberdeen
Ewa
Wells Fargo & Company
Two Sigma Securities

View all funds holding Affimed Therapeutics B V